免疫诊断市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003722
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 270
Buy Now

【研究报告】免疫诊断市场规模预计将从2022年的1921889万美元增长到2030年的3448780万美元;预计2022年至2030年免疫诊断市场的复合年增长率为7.6%。

分析师观点:

由于免疫诊断市场的大幅增长,预计免疫诊断市场将蓬勃发展。诊断领域的发展。 COVID-19 大流行期间,免疫诊断市场增长得到推动。许多公司的产品都获得了紧急授权,这有助于他们在市场上进行商业化。此外,市场的增长主要归因于对更快诊断技术的研发投资的增加。公司做出了各种战略决策来扩大其产品组合和地域分布。此外,预期寿命的提高导致老年人口显着增加,从而导致对免疫诊断的需求增加。此外,人们意识的增强和健康标准的变化增加了对早期诊断的需求,从而推动了对各种诊断设备的需求。此外,人们对免疫诊断学的发展及其益处的认识也增加了免疫诊断技术的使用。

市场概况:

免疫诊断学是指主要以抗原抗体反应为主要检测手段的诊断方法。特定于所需抗原的抗体可以与放射性标记、荧光标记或成色酶缀合,并用作检测它的探针。此类测试的速度、准确性和简单性促进了用于诊断疾病、微生物甚至体内非法药物的快速技术的发展。推动传染病患病率上升和床旁护理使用不断增加的关键因素推动了免疫诊断市场的增长。然而,报销不足阻碍了市场的增长。从地理位置上看,北美是最大的市场,其次是欧洲。在北美,美国占据免疫诊断市场最大的市场份额。亚太地区是全球免疫诊断市场增长最快的地区。在亚太地区,中国是最大的免疫诊断市场,预计在预测期内将保持其主导地位。

战略洞察

市场驱动力:
传染病发病率不断上升

对由病毒、真菌、细菌、寄生虫或其有毒产物等传染源引起的几种不断增长的传染病的诊断和治疗,导致处方数量激增。免疫诊断测试,例如补体结合、沉淀测试、凝集测试、线印迹测定、蛋白质印迹测定、酶免疫测定(EIA)和免疫荧光测试。

人类免疫缺陷病毒(HIV)仍然是一种全球重大公共卫生问题。根据联合国艾滋病毒/艾滋病联合规划署 (UNAIDS) 的数据,2021 年,全球约有 3840 万人感染艾滋病毒。此外,肝炎是推动免疫诊断市场的另一个主要因素。据世界卫生组织 (WHO) 统计,全球有近 5800 万人患有慢性丙型肝炎感染,每年新增 150 万人。此外,约有 320 万青少年和儿童感染丙型肝炎。经所有成员国批准,世卫组织全球肝炎战略的目标是在 2016 年至 2030 年期间将新发肝炎感染率降低 90%,死亡率降低 65%。此类全球举措正在推动对免疫诊断产品的需求。

此外,结核病 (TB)、COVID-19 和其他医院获得性感染 (HAI) 需要免疫诊断测试。

> 结核病已成为第 13 大死因,也是仅次于 COVID-19 的第二大传染病杀手。 2020 年,全球有 150 万人死于结核病,估计有 1000 万人受到影响,其中包括 560 万男性、330 万女性和 110 万儿童。 2021 年,CDC 国家结核病监测系统共报告了 7,860 例结核病病例( NTSS)由美国 50 个州和哥伦比亚特区 (DC) 统计。根据 Worldometer,全球报告了数百万人因 COVID-19 大流行而死亡。它给医疗保健系统带来了压力,并增加了对免疫诊断测试的需求。诊断在确定合适的医疗方法方面发挥着至关重要的作用。免疫诊断有助于诊断严重影响免疫系统的疾病。因此,传染病患病率的上升导致对免疫诊断产品的需求激增。

细分分析:

全球免疫诊断市场分为产品、临床适应症和最终用途用户。根据产品,市场分为酶联免疫吸附测定(ELISA)、化学发光免疫测定(CLIA)、放射免疫测定(RIA)等。按产品划分,酶联免疫吸附测定 (ELISA) 领域占据了最大的市场份额。传染病是由细菌、病毒、寄生虫、真菌等有害病原体进入人体引起的。它们通常通过受污染的食物或水以及虫咬传播。传染病占据了免疫诊断市场的很大一部分。进行免疫诊断测试是为了补充传染病研究中分子测定的结果。多种免疫诊断测试用于诊断传染病、检测内分泌和肿瘤疾病以及测量血液药物浓度。基于酶的免疫测定使用抗体来检测抗原并定量抗体。蛋白质印迹测试涉及根据抗体与通过印迹固定在膜上的目标抗原(病毒成分)之间的反应来检测患者样本(例如血清或不同体液)中的抗体。

化学发光免疫分析(CLIA) )细分市场预计在预测期内复合年增长率最高。 CLIA细分市场进一步细分为维生素D测定、HIV检测、HIV AG/AB组合测定等。

根据临床适应症,市场细分为传染病、肝炎+hiv、内分泌学、胃肠、代谢等。传染病在 2022 年获得了最高的市场价值,预计在预测期内复合年增长率最高。传染病部分进一步细分为 COVID-19、结核病、莱姆病、感染管理、寨卡病毒、密螺旋体、TORCH、麻疹和腮腺炎、水痘带状疱疹病毒和 EB 病毒。同样,内分泌领域进一步分为高血压、生长、糖尿病、甲状腺和生殖内分泌。

根据最终用户,免疫诊断市场分为医院、诊所、诊断实验室、学术和研究研究所等。到 2022 年,医院细分市场占据最大的市场份额。预计诊所细分市场在预测期内的复合年增长率最高。

区域分析:

北美持有全球免疫诊断市场份额最大,2022年价值97.728亿美元,复合年增长率为7.5%。北美是最大的免疫诊断市场,其中美国、加拿大和墨西哥是该区域市场的主要贡献者。政府对采用先进诊断技术的日益支持、不断加大的研发力度以及市场参与者的战略合作等举措都有助于免疫诊断市场的显着增长。此外,诊断行业参与者的技术进步可能会成为未来几年北美免疫诊断市场的主要增长动力。同时,亚太地区是全球免疫诊断市场增长最快的地区。美国是最大的市场,免疫诊断的增长是由癌症患病率的增加以及免疫诊断领域的不断发展推动的。

亚太免疫诊断市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。亚太地区慢性病发病率的增加导致对诊断测试的需求很高,这些测试可以提供与疾病相关的医疗保健的基本细节以及检测、诊断和治疗。此外,国内企业对开发免疫诊断产品和技术的投资可能会推动预测期内免疫诊断市场的增长。

主要参与者分析:

免疫诊断市场主要包括雅培实验室、罗氏公司、DiaSorin SpA、丹纳赫公司、赛默飞世尔科技公司、珀金埃尔默公司、深圳迈瑞生物医疗电子有限公司、生物梅里埃公司、Svar Life Science AB 和西门子等公司Healthineers AG.

雅培实验室和罗氏有限公司是免疫诊断市场的两大参与者。这些公司一直在实施各种战略,这些战略有助于公司的发展,反过来又给市场带来了各种变化。这些公司采用了有机战略,例如推出、扩张和产品批准。另一方面,无机策略,如产品发布、合作伙伴关系和协作,在免疫诊断市场中广泛存在。

最新发展:

无机和有机策略是被免疫诊断市场的公司广泛采用。下面列出了最近的一些关键市场动态:

2023 年 4 月,Thermo Fisher Scientific 宣布与全球诊断领域的领导者 ALPCO-GeneProof 建立合作伙伴关系。此次合作帮助推出了 TaqPath Menu | GeneProof PCR 试剂盒上市。 2022年7月,雅培诊断宣布参加2022年美国临床化学协会(AACC)。在展会上,该公司展示了其诊断系统和分析仪。2023年5月,赛默飞世尔科技宣布美国FDA已批准其免疫分析, B·R·A·H·M·S PlGF 加上 KRYPTOR 和 B·R·A·H·M·S sFlt-1 KRYPTOR 新型生物标志物。这些免疫测定评估先兆子痫(一种严重的妊娠并发症)的风险和临床管理。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Immunodiagnostics?

Immunodiagnostics is referred as a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies specific for a desired antigen can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy and simplicity of such tests has led to the development of rapid techniques for the diagnosis of disease, microbes and even illegal drugs in vivo.

What are the driving factors for the global immunodiagnostics market across the world?

The factors that are driving the growth of the immunodiagnostics market are the rising prevalence of infectious diseases and the growing use of point-of-care immunodiagnostics.

Who are the major players in the immunodiagnostics market across the globe?

The immunodiagnostics market majorly consists of the players, such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, bioMerieux SA, Svar Life Science AB, and Siemens Healthineers AG.

Which segment by type led the immunodiagnostics market?

The enzyme-linked immunosorbent assays (ELISA) segment held the largest share of the market in 2022. Whereas the chemiluminescence immunoassays (CLIA) segment is estimated to register the highest CAGR in the market during the forecast period.

Which region is projected to be the fastest-growing region in the global immunodiagnostics market?

The Asia Pacific is expected to be the fastest-growing region in the immunodiagnostics market over the forecast period due to the infectious diseases and the growing use of point-of-care immunodiagnostics, and developments by market players offering immunodiagnostics.

What is the market CAGR value of the immunodiagnostics market during the forecast period?

The CAGR value of the immunodiagnostics market during the forecasted period of 2022-2028 is 7.6%.

What are the growth estimates for the immunodiagnostics market till 2028?

The immunodiagnostics market is expected to be valued at US$ 34,487.80 million in 2030.

What is the estimated immunodiagnostics market size in 2022?

The immunodiagnostics market is estimated to be valued at US$ 19,218.89 million in 2022.

The List of Companies - Immunodiagnostics Market

  1. Abbott Laboratories
  2. F. Hoffmann-La Roche Ltd
  3. DiaSorin SpA
  4. Danaher Corporation
  5. Thermo Fisher Scientific Inc
  6. PerkinElmer Inc
  7. Shenzhen Mindray Bio-Medical Electronics Co Ltd
  8. bioMerieux SA
  9. Svar Life Science AB
  10. Siemens Healthineers AG.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports